Exagen (XGN) Non-Current Deferred Tax Liability (2018 - 2022)
Historic Non-Current Deferred Tax Liability for Exagen (XGN) over the last 5 years, with Q4 2022 value amounting to $1.4 million.
- Exagen's Non-Current Deferred Tax Liability rose 3695.44% to $1.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $1.4 million, marking a year-over-year increase of 3695.44%. This contributed to the annual value of $1.4 million for FY2022, which is 3695.44% up from last year.
- According to the latest figures from Q4 2022, Exagen's Non-Current Deferred Tax Liability is $1.4 million, which was up 3695.44% from $306000.0 recorded in Q3 2022.
- Exagen's Non-Current Deferred Tax Liability's 5-year high stood at $1.4 million during Q4 2022, with a 5-year trough of $147000.0 in Q1 2020.
- Moreover, its 5-year median value for Non-Current Deferred Tax Liability was $306000.0 (2022), whereas its average is $448000.0.
- Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first crashed by 4000.0% in 2020, then surged by 9367.09% in 2022.
- Quarter analysis of 5 years shows Exagen's Non-Current Deferred Tax Liability stood at $672000.0 in 2018, then increased by 8.93% to $732000.0 in 2019, then grew by 8.61% to $795000.0 in 2020, then grew by 29.69% to $1.0 million in 2021, then skyrocketed by 36.95% to $1.4 million in 2022.
- Its last three reported values are $1.4 million in Q4 2022, $306000.0 for Q3 2022, and $306000.0 during Q2 2022.